Performance of JNJ Johnson & Johnson | 6.6% in 12m
Compare JNJ with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Johnson & Johnson with its related Sector/Index XLV
Performance Duell JNJ vs XLV
TimeFrame | JNJ | XLV |
---|---|---|
1 Day | 0.15% | 0.01% |
1 Week | 1.57% | 1.44% |
1 Month | -2.08% | 1.54% |
3 Months | 1.03% | 8.83% |
6 Months | 1.64% | 14.81% |
12 Months | 6.59% | 18.19% |
YTD | -1.11% | 6.83% |
Rel. Perf. 1m | -0.32 | |
Rel. Perf. 3m | -0.87 | |
Rel. Perf. 6m | -1.33 | |
Rel. Perf. 12m | -1.09 |
Is Johnson & Johnson a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Johnson & Johnson (NYSE:JNJ) is currently (March 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 7.82 and therefor a positive outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JNJ as of March 2024 is 147.50. This means that JNJ is currently overvalued and has a potential downside of -6.76%.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JNJ as of March 2024 is 147.50. This means that JNJ is currently overvalued and has a potential downside of -6.76%.
Is JNJ a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 13
- Sell: 0
- Strong Sell: 0
Values above 0%: JNJ is performing better - Values below 0%: JNJ is underperforming
Compare JNJ with Broad Market Indices
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 1.40% | -5.72% | -21.30% | -27.55% |
US NASDAQ 100 | QQQ | 1.99% | -4.22% | -22.86% | -38.95% |
US Dow Jones Industrial 30 | DIA | 1.57% | -4.42% | -17.63% | -18.63% |
German DAX 40 | DBXD | -0.20% | -7.16% | -18.94% | -14.86% |
UK FTSE 100 | ISFU | 0.81% | -7.01% | -8.53% | -6.40% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.45% | -3.90% | 6.07% | 22.28% |
Hongkong Hang Seng | HSI | 5.11% | 2.64% | 7.74% | 27.14% |
Japan Nikkei 225 | EXX7 | 2.11% | -5.63% | -20.22% | -21.72% |
India NIFTY 50 | INDA | -0.53% | -3.12% | -14.95% | -28.01% |
Brasil Bovespa | EWZ | 1.97% | 0.71% | -8.57% | -22.34% |
JNJ Johnson & Johnson vs. Sectors
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.56% | -6.17% | -22.84% | -40.93% |
Consumer Discretionary | XLY | 1.81% | -2.69% | -13.65% | -24.19% |
Consumer Staples | XLP | 1.11% | -5.23% | -10.67% | -0.35% |
Energy | XLE | -0.38% | -13.11% | -2.52% | -14.33% |
Financial | XLF | 1.04% | -6.83% | -25.26% | -29.90% |
Health Care | XLV | 0.13% | -3.62% | -13.17% | -11.60% |
Industrial | XLI | 1.32% | -6.82% | -23.01% | -23.81% |
Materials | XLB | 0.54% | -9.36% | -17.67% | -15.34% |
Real Estate | XLRE | 0.42% | -4.65% | -16.83% | -9.49% |
Technology | XLK | 2.32% | -3.99% | -26.34% | -39.07% |
Utilities | XLU | -1.38% | -8.70% | -11.93% | 3.62% |
Aerospace & Defense | XAR | 1.02% | -4.74% | -24.46% | -16.75% |
Biotech | XBI | 1.90% | 4.46% | -27.01% | -20.89% |
Homebuilder | XHB | 1.08% | -11.38% | -43.63% | -64.73% |
Retail | XRT | 0.48% | -6.28% | -29.92% | -24.90% |
Does Johnson & Johnson outperform its market, is JNJ a Sector Leader?
No, over the last 12 months Johnson & Johnson (JNJ) made 6.59%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 18.19%.
Over the last 3 months JNJ made 1.03%, while XLV made 8.83%.
No, over the last 12 months Johnson & Johnson (JNJ) made 6.59%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 18.19%.
Over the last 3 months JNJ made 1.03%, while XLV made 8.83%.
Period | JNJ | XLV | S&P 500 |
---|---|---|---|
1 Month | -2.08% | 1.54% | 3.64% |
3 Months | 1.03% | 8.83% | 10.07% |
12 Months | 6.59% | 18.19% | 34.14% |